Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
Direct interaction of adenosine with the TRPV1 channel protein.
Puntambekar P
,
Van Buren J
,
Raisinghani M
,
Premkumar LS
,
Ramkumar V
.
???displayArticle.abstract???
Vanilloid receptor 1 (TRPV1), a nonspecific cation channel expressed primarily in small sensory neurons, mediates inflammatory thermal pain sensation. The function and expression of TRPV1 are enhanced during inflammation and certain neuropathies, leading to sustained hyperalgesia. Activation of TRPV1 in the spinal cord and periphery promotes release of adenosine, which produces analgesia by activating A(1) and A(2A) adenosine receptor (AR) on central and peripheral neurons. This study provides evidence of a direct interaction of AR analogs with TRPV1. Adenosine analogs inhibit TRPV1-mediated Ca(2+) entry in human embryonic kidney (HEK293) cells stably expressing TRPV1 (HEK/TRPV1) and DRG neurons. This inhibition was independent of A(2A)AR activation. Specific binding of [(3)H]resiniferatoxin (RTX) in plasma membrane preparations was inhibited by CGS21680, an A(2A)AR agonist. Similar degrees of inhibition were observed with both agonists and antagonists of ARs. Adenosine analogs inhibited [(3)H]RTX binding to affinity-purified TRPV1, indicative of a direct interaction of these ligands with the receptor. Furthermore, specific capsaicin-sensitive binding of [(3)H]CGS21680 was observed in Xenopus oocyte membranes expressing TRPV1. Capsaicin-induced inward currents in DRG neurons were inhibited by adenosine and agonist and antagonist of A(2A)AR at nanomolar concentrations. Increasing the concentrations of capsaicin reversed the inhibitory response to capsaicin, suggesting a competitive inhibition at TRPV1. Finally, exposure of HEK/TRPV1 cells to capsaicin induced an approximately 2.4-fold increase in proapoptotic cells that was abolished by adenosine analogs. Together, these data suggest that adenosine could serve as an endogenous inhibitor of TRPV1 activity by directly interacting with the receptor protein.
Amaya,
Local inflammation increases vanilloid receptor 1 expression within distinct subgroups of DRG neurons.
2003, Pubmed
Amaya,
Local inflammation increases vanilloid receptor 1 expression within distinct subgroups of DRG neurons.
2003,
Pubmed
Bradford,
A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding.
1976,
Pubmed
Cahill,
Involvement of calcium channels in depolarization-evoked release of adenosine from spinal cord synaptosomes.
1993,
Pubmed
Caterina,
Impaired nociception and pain sensation in mice lacking the capsaicin receptor.
2000,
Pubmed
Caterina,
The capsaicin receptor: a heat-activated ion channel in the pain pathway.
1997,
Pubmed
,
Xenbase
Chizh,
P2X receptors and nociception.
2001,
Pubmed
Chuang,
Bradykinin and nerve growth factor release the capsaicin receptor from PtdIns(4,5)P2-mediated inhibition.
2001,
Pubmed
,
Xenbase
Davis,
Vanilloid receptor-1 is essential for inflammatory thermal hyperalgesia.
2000,
Pubmed
Deuchars,
Adenosine A1 receptors reduce release from excitatory but not inhibitory synaptic inputs onto lateral horn neurons.
2001,
Pubmed
Eisenach,
Preliminary efficacy assessment of intrathecal injection of an American formulation of adenosine in humans.
2002,
Pubmed
Guo,
Immunocytochemical localization of the vanilloid receptor 1 (VR1): relationship to neuropeptides, the P2X3 purinoceptor and IB4 binding sites.
1999,
Pubmed
Guroff,
The action of adenosine analogs on PC12 cells.
1981,
Pubmed
Hudson,
VR1 protein expression increases in undamaged DRG neurons after partial nerve injury.
2001,
Pubmed
Jambrina,
Calcium influx through receptor-operated channel induces mitochondria-triggered paraptotic cell death.
2003,
Pubmed
Jarvis,
Analgesic and anti-inflammatory effects of A-286501, a novel orally active adenosine kinase inhibitor.
2002,
Pubmed
Kaelin-Lang,
Expression of adenosine A2a receptor gene in rat dorsal root and autonomic ganglia.
1998,
Pubmed
Kitakaze,
Alpha 1-adrenoceptor activation increases ecto-5'-nucleotidase activity and adenosine release in rat cardiomyocytes by activating protein kinase C.
1995,
Pubmed
Laemmli,
Cleavage of structural proteins during the assembly of the head of bacteriophage T4.
1970,
Pubmed
Latini,
Adenosine in the central nervous system: release mechanisms and extracellular concentrations.
2001,
Pubmed
Lee,
Pharmacology of the spinal adenosine receptor which mediates the antiallodynic action of intrathecal adenosine agonists.
1996,
Pubmed
Liu,
Involvement of primary sensory afferents, postganglionic sympathetic nerves and mast cells in the formalin-evoked peripheral release of adenosine.
2001,
Pubmed
Maccarrone,
Anandamide induces apoptosis in human cells via vanilloid receptors. Evidence for a protective role of cannabinoid receptors.
2000,
Pubmed
Nie,
A role of p75 in NGF-mediated down-regulation of the A(2A) adenosine receptors in PC12 cells.
1999,
Pubmed
Noronha-Blob,
Pharmacological profile of adenosine A2 receptor in PC12 cells.
1986,
Pubmed
Obata,
Histamine increases interstitial adenosine concentration via activation of ecto-5'-nucleotidase in rat hearts in vivo.
2001,
Pubmed
Obata,
Adenosine production and its interaction with protection of ischemic and reperfusion injury of the myocardium.
2002,
Pubmed
Palmer,
125I-4-(2-[7-amino-2-[2-furyl][1,2,4]triazolo[2,3-a][1,3,5] triazin-5-yl-amino]ethyl)phenol, a high affinity antagonist radioligand selective for the A2a adenosine receptor.
1995,
Pubmed
Pedata,
Adenosine extracellular brain concentrations and role of A2A receptors in ischemia.
2001,
Pubmed
Poon,
Antinociception by adenosine analogs and inhibitors of adenosine metabolism in an inflammatory thermal hyperalgesia model in the rat.
1998,
Pubmed
Premkumar,
Induction of vanilloid receptor channel activity by protein kinase C.
,
Pubmed
,
Xenbase
Ramkumar,
Adenosine, oxidative stress and cytoprotection.
2001,
Pubmed
Rane,
Intrathecal adenosine administration: a phase 1 clinical safety study in healthy volunteers, with additional evaluation of its influence on sensory thresholds and experimental pain.
1998,
Pubmed
Sawynok,
Adenosine in the spinal cord and periphery: release and regulation of pain.
2003,
Pubmed
Sawynok,
Adenosine receptor activation and nociception.
1998,
Pubmed
Sweeney,
Morphine, capsaicin and K+ release purines from capsaicin-sensitive primary afferent nerve terminals in the spinal cord.
1989,
Pubmed
Szallasi,
The cloned rat vanilloid receptor VR1 mediates both R-type binding and C-type calcium response in dorsal root ganglion neurons.
1999,
Pubmed
Tominaga,
Potentiation of capsaicin receptor activity by metabotropic ATP receptors as a possible mechanism for ATP-evoked pain and hyperalgesia.
2001,
Pubmed
Tominaga,
The cloned capsaicin receptor integrates multiple pain-producing stimuli.
1998,
Pubmed
,
Xenbase